Cargando…
Is optimal first-line chemotherapy deliverable in all newly diagnosed ovarian cancers? A population-based study
NICE guidance recommends the use of paclitaxel and a platinum therapy for all cases of ovarian cancer. We report our experience of treating 133 patients with ovarian cancer over a 3-year period. Where indicated, 91% received chemotherapy. A taxane/platinum combination was found to be appropriate in...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376968/ https://www.ncbi.nlm.nih.gov/pubmed/12966409 http://dx.doi.org/10.1038/sj.bjc.6601071 |